Eupraxia Pharmaceuticals (EPRX)

• Market cap: $280M
• 1 day: 3.94%
• 5 days: -0.18%
• 1 month: -6.1%
• 3 months: 2.59%
• 6 months: 35.12%
• Year to date: 77%
• 1 year: 78.71%
• 5 years: 87.8%
• 10 years: 87.8%
• Sector: Healthcare
• Industry: Biotechnology

About: Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with unmet medical needs.

Employees: 33